By comparing the clinicopathological characteristics of patients with HNSCC with the ACSS2 expression levels, it can be known that patients with high ACSS2 expression presented with later tumor stages and extended lymph node metastases (Table 1). This evidence concerns the gene ACSS2 and head and neck squamous cell carcinoma.